Skip to content
Tonyajoy.com
Tonyajoy.com

Transforming lives together

  • Home
  • Helpful Tips
  • Popular articles
  • Blog
  • Advice
  • Q&A
  • Contact Us
Tonyajoy.com

Transforming lives together

19/08/2022

What is the function of BCR-ABL?

Table of Contents

Toggle
  • What is the function of BCR-ABL?
  • Which targeted therapy will be use if BCR-ABL mutation is positive?
  • How does the BCR-ABL protein affect intracellular signaling pathways?
  • Is BCR-ABL a gene or protein?
  • How does the BCR-ABL protein promote the development of CML?
  • What does the BCR-ABL fusion gene lead to?
  • How does the BCR ABL protein affect intracellular signaling pathways?
  • What was the result of inhibiting BCR-ABL?
  • What is BCR-ABL translocation?

What is the function of BCR-ABL?

Bcr-Abl induces mitogenesis in fibroblast and hematopoietic cell transformation models (reviewed in reference 31) and protects cells from apoptosis induced by numerous stimuli including cytokine withdrawal, DNA damage, and Fas activation (2, 3, 12, 24–26).

Which targeted therapy will be use if BCR-ABL mutation is positive?

Imatinib. Imatinib (Gleevec) was the first drug to specifically target the BCR-ABL tyrosine kinase protein.

Does BCR-ABL stimulate the cell cycle?

Significance. CML is a two-stage disease in which the initial hyperproliferative phase is followed by a second lethal phase designated blast crisis. Extensive work has demonstrated that the BCR/ABL oncogene directly causes increased proliferation of cells and leads to myeloid hyperproliferation.

Does BCR-ABL stimulate or inhibit the cell cycle?

These data show that Bcr-Abl is one of a select group of oncogenes that is capable of both inhibiting apoptosis and deregulating cell proliferation.

How does the BCR-ABL protein affect intracellular signaling pathways?

The BCR-ABL1 protein is a constitutively activated tyrosine kinase, which causes anomalous activation of intracellular signal transduction pathways, leading to an unstable genome, abnormal cellular proliferation, and amplification of CML clones (1).

Is BCR-ABL a gene or protein?

A protein made from pieces of two genes that get joined together. It is found in most patients with chronic myelogenous leukemia (CML), and in some patients with acute lymphoblastic leukemia (ALL) or acute myelogenous leukemia (AML).

What protein is encoded by BCR-ABL?

The BCR-ABL fusion oncogene encodes new fusion proteins of 190, 210 and 230 kDa molecular weight [6, 7]. The p210BCR-ABL isoforms have an increased level of tyrosine kinase activity, which is important for the development of the disease [8].

What is the Philadelphia chromosome?

The Philadelphia chromosome forms when chromosome 9 and chromosome 22 break and exchange portions. This creates an abnormally small chromosome 22 and a new combination of instructions for your cells that can lead to the development of chronic myelogenous leukemia.

How does the BCR-ABL protein promote the development of CML?

The swapping of DNA between the chromosomes leads to the formation of a new gene (an oncogene) called BCR-ABL. This gene then produces the BCR-ABL protein, which is the type of protein called a tyrosine kinase. This protein causes CML cells to grow and divide out of control.

What does the BCR-ABL fusion gene lead to?

If your results show you have the BCR-ABL gene, as well as an abnormal amount of white blood cells, you will probably be diagnosed with chronic myeloid leukemia (CML) or Ph-positive, acute lymphoblastic leukemia (ALL).

Is BCR-ABL the same as Philadelphia chromosome?

Philadelphia chromosome. A piece of chromosome 9 and a piece of chromosome 22 break off and trade places. The BCR-ABL gene is formed on chromosome 22 where the piece of chromosome 9 attaches. The changed chromosome 22 is called the Philadelphia chromosome.

What do the BCR and ABL genes do?

A BCR-ABL test is most often used to diagnose or rule out chronic myeloid leukemia (CML) or a specific form of acute lymphoblastic leukemia (ALL) called Ph-positive ALL. Ph-positive means a Philadelphia chromosome was found. The test is not used to diagnose other types of leukemia.

How does the BCR ABL protein affect intracellular signaling pathways?

What was the result of inhibiting BCR-ABL?

Bcr-Abl mutation Point mutations can cause amino acid substitutions inside the kinase domain of the Bcr-Abl protein and disrupt the binding site of imatinib on the tyrosine kinase, resulting in a loss of sensitivity to the drug.

How is BCR-ABL activated?

ABL tyrosine kinase activity is constitutively activated by the juxtaposition of BCR, thus favoring dimerization or tetramerization and subsequent autophosphorylation.

How do BCR-ABL inhibitors work?

Imatinib binds to Abl domain via six hydrogen bond interactions. This stabilizes the imatinib Bcr-Abl complex and prevents ATP from reaching its binding site.

What is BCR-ABL translocation?

The BCR-ABL mutation happens when pieces of BCR and ABL genes break off and switch places. The piece of chromosome 9 that breaks off includes part of the ABL gene. When this piece moves over to chromosome 22, part of the ABL gene attaches to the BCR gene. The merged gene is called the BCR-ABL fusion gene.

Popular articles

Post navigation

Previous post
Next post

Recent Posts

  • Is Fitness First a lock in contract?
  • What are the specifications of a car?
  • Can you recover deleted text?
  • What is melt granulation technique?
  • What city is Stonewood mall?

Categories

  • Advice
  • Blog
  • Helpful Tips
©2026 Tonyajoy.com | WordPress Theme by SuperbThemes